Eczema Topical, Drug Exposure

This concept set was developed by a data scientist (KH) for a study led by CHOP clinicians Dr. Jonathan Spergel and Dr. Stan Gabryszewski, which investigates dupilumab use and autoimmune diseases in patients with asthma and atopic dermatitis. The codeset was used to identify a cohort of patients with moderate-to-severe atopic disease, including patients who used moderate-to-severe eczema topicals. The codeset is designed for use with the PEDSnet data model and includes a "severity" column indicating the drug severity (mild, moderate or severe) and a "drug" column indicating one of 28 drugs.